Trident Texofab Ltd — Important, 12-02-2026: Company Update

Trident Texofab has confirmed the utilization of funds raised from its preferential issue of warrants. The company raised Rs. 40.86 Crore, intended for working capital and general corporate purposes. As of December 31, 2025, Rs. 36.07 Crore of these funds have been utilized. The company reported no deviation or variation from the stated objectives, with both the Audit Committee and statutory auditors noting no concerns. This ensures investors that the capital is being deployed as planned, reflecting good financial discipline.